Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Filings indexed 102 across all filing types
Latest filing 2025-04-25 Board/Management Inform…
Country JP Japan
Listing T 7733

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
臨時報告書
Board/Management Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau. Section 1 explicitly states the reason for filing: a resolution was made by the Board of Directors on April 25, 2025, regarding the appointment of a new Representative Executive Officer (新任代表執行役の任命について決議いたしました). Section 2 details the new appointee, Bob White, his new role (Representative Executive Officer, President & CEO), and his effective date (June 1, 2025). This content directly relates to changes in senior management/board composition. This aligns perfectly with the definition for Board/Management Information (MANG).
2025-04-25 Japanese
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書(法24条の6第1項に基づくもの)" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)". The filing explicitly states the basis is Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act, and the reporting period is for December 2024. This type of filing specifically reports on the company's treasury stock repurchase activities during a defined period. Reviewing the provided definitions, none perfectly match a specific 'Treasury Stock Report'. However, the content details capital structure changes related to share transactions (repurchases). The closest fit among the provided codes that deals with share transactions is 'POS' (Transaction in Own Shares), which covers share repurchase/issuance. Since this is a mandatory regulatory report detailing the status of share repurchases, POS is the most appropriate classification, as it directly relates to the company's transaction in its own shares.
2025-01-10 Japanese
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly cites the legal basis as "金融商品取引法第24条の6第1項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). It details the acquisition status of treasury stock for the reporting period of November 1, 2024, to November 30, 2024. This type of filing, reporting on the company's own share transactions, directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing, POS is a more specific category than the general RNS fallback.
2024-12-09 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains a table header indicating it is a '確認書' (Confirmation document) related to the '第2四半期報告書' (Second Quarter Report) for the period ending September 30, 2024. The content explicitly states that the representative director confirms the appropriateness of the '半期報告書' (Half-Year Report) filing based on the Financial Instruments and Exchange Act. A comprehensive report covering a period shorter than a year (half-year) falls under the definition of an Interim/Quarterly Report (IR). Although this specific document is a confirmation *of* the report, its core subject matter is the official half-year financial disclosure, making 'IR' the most appropriate classification for the underlying report type being referenced and confirmed, rather than a general RPA or RNS, given the specific regulatory context (Financial Instruments and Exchange Act filing for a half-year period). The document length is very short (592 chars), but it is not merely announcing a report; it is a formal confirmation statement *about* the required half-year filing.
2024-11-08 Japanese
半期報告書-第157期(2024/04/01-2025/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第2四半期報告書' (Second Quarter Report) for Olympus Corporation, covering the period from April 1, 2024, to September 30, 2024. It contains detailed financial statements, management analysis (MDA), and segment reporting, which are characteristic of an interim/quarterly financial report. It is not a mere announcement (RPA) or a certification, as it provides comprehensive financial data and analysis. H1 2025
2024-11-08 Japanese
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly states its legal basis as "金融商品取引法第24条の6第1項" (Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act). It details the acquisition of the company's own shares (treasury stock) over a specific reporting period (October 1 to October 31, 2024). This type of filing, reporting on share repurchases, directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is a specific regulatory report detailing share transactions, not a general announcement of a report (RPA) or a general regulatory filing (RNS).
2024-11-08 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.